Peter S. Knight
Director, PAR PHARMACEUTICAL COMPANIES, INC.
Companies
- bioAffinity Technologies, Inc.Board member Dec 5, 2022 to now1
- CASI Pharmaceuticals, Inc (DE)Board member Jun 19, 2006 to Jan 28, 20102
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- bioAffinity Technologies, Inc. BIAF117,455 shares3$419.3K at $3.57Jul 1, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2024Granted 33,784 shares of bioAffinity Technologies, Inc.3
- Jun 12, 2024Granted 8,296 shares of bioAffinity Technologies, Inc.4
- Jan 1, 2024Granted 12,668 shares at $1.48 of bioAffinity Technologies, Inc.5
- Oct 1, 2023Granted 11,867 shares at $1.58 of bioAffinity Technologies, Inc.5
- Jul 1, 2023Granted 10,245 shares at $1.83 of bioAffinity Technologies, Inc.6
- Apr 15, 2023Granted 9,920 shares at $1.89 of bioAffinity Technologies, Inc.6
- Jan 1, 2023Granted 8,227 shares at $2.28 of bioAffinity Technologies, Inc.6
- Aug 31, 2022Bought 8,163 shares of bioAffinity Technologies, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jun 14, 2024
- 5SEC EDGARForm 4 filed Jan 24, 2024
- 6SEC EDGARForm 4 filed Jul 6, 2023
- 7SEC EDGARForm 4 filed Dec 5, 2022